“哦，你将去的地方”：21 世纪国家生物医学研究企业的转型。

"Oh, the places you'll go": transformation of the nation's biomedical research enterprise in the 21st century.

机构信息

Clinical and Translational Science Institute, University of California, San Francisco, CA, USA.

出版信息

J Sport Rehabil. 2010 Nov;19(4):359-68. doi: 10.1123/jsr.19.4.359.

DOI:10.1123/jsr.19.4.359

Abstract

The postgenomic era and heightened public expectations for tangible improvements in the public health have stimulated a complete transformation of the nation's biomedical research enterprise. The National Institutes of Health (NIH) "Roadmap for Medical Research" has catalyzed this transformation. The NIH roadmap consists of several interrelated initiatives, of which the Clinical and Translational Science Award (CTSA) program is the most relevant for rehabilitation specialists. This article reviews the evolution of this transformation and highlights the unprecedented opportunities the CTSA program provides rehabilitation specialists to play leadership roles in improving the clinical care of their patients.

摘要

后基因组时代和公众对公共卫生方面切实改善的期望日益提高，刺激了全国生物医学研究事业的彻底转变。美国国立卫生研究院（NIH）的“医学研究路线图”催化了这一转变。NIH 路线图包含若干相互关联的计划，其中与康复专家最相关的是临床与转化科学奖（CTSA）计划。本文回顾了这一转变的演进，并强调了 CTSA 计划为康复专家提供的前所未有的机会，使他们能够在改善患者临床护理方面发挥领导作用。